• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/9/23 12:27:37 PM ET
    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $TSVT alert in real time by email

     

    On Wednesday, 155 companies set new 52-week lows.

    Interesting Points From Today's 52-Week Highs And Lows:

    • The largest company by market cap to set a new 52-week low was Estee Lauder Cos (NYSE:EL).
    • The smallest company by market cap to set a new 52-week low was SenesTech (NASDAQ:SNES).
    • Siyata Mobile (NASDAQ:SYTA)'s stock fell the most, as it traded down 7658.62% to reach a new 52-week low.
    • Sutro Biopharma (NASDAQ:STRO) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low.

    The following stocks set new 52-week lows on Wednesday:

    • Estee Lauder Cos (NYSE:EL) stock broke to a new 52-week low of $165.94 on Wednesday. Shares of the company traded down 0.82%.
    • Kellogg (NYSE:K) shares fell to $63.03 on Wednesday, setting a new 52-week low with a shift of up 1.32%.
    • Conagra Brands (NYSE:CAG) stock hit a new 52-week low of $31.07. The stock was up 0.86% on the session.
    • Campbell Soup (NYSE:CPB) stock drifted up 2.04% on Wednesday morning to hit a new 52-week low of $43.24.
    • FMC (NYSE:FMC) shares set a new yearly low of $86.64 this morning. The stock was down 1.78% on the session.
    • Valmont Industries (NYSE:VMI) shares made a new 52-week low of $247.07 on Wednesday. The stock was down 0.09% for the day.
    • Liberty Live (NASDAQ:LLYVA) stock broke to a new 52-week low of $32.08 on Wednesday. Shares of the company traded up 0.61%.
    • WNS (Hldgs) (NYSE:WNS) stock drifted down 0.66% on Wednesday morning to hit a new 52-week low of $63.16.
    • Atlantica Sustainable (NASDAQ:AY) shares hit a yearly low of $22.27. The stock was up 0.36% on the session.
    • Nuvei (NASDAQ:NVEI) shares made a new 52-week low of $18.58 on Wednesday. The stock was down 37.37% for the day.
    • Outfront Media (NYSE:OUT) shares were up 3.75% for the day, having made a 52-week low of $11.36.
    • Agiliti (NYSE:AGTI) shares moved down 18.85% on Wednesday to hit a new 52-week low of $13.24, drifting down 18.85%.
    • Frontier Group Holdings (NASDAQ:ULCC) shares set a new yearly low of $7.52 this morning. The stock was down 2.57% on the session.
    • Impinj (NASDAQ:PI) stock broke to a new 52-week low of $55.51 on Wednesday. Shares of the company traded down 3.06%.
    • Duckhorn Portfolio (NYSE:NAPA) shares reached a new 52-week low of $12.32 on Wednesday morning, moving down 0.8%.
    • Xencor (NASDAQ:XNCR) stock hit $23.22 on Wednesday morning, setting a new 52-week low for a change of down 2.51%.
    • Nu Skin Enterprises (NYSE:NUS) stock drifted down 1.67% on Wednesday morning to hit a new 52-week low of $25.23.
    • Everi Hldgs (NYSE:EVRI) shares were down 11.7% for the day, having made a 52-week low of $12.71.
    • Harmonic (NASDAQ:HLIT) shares set a new 52-week low of $10.03. The stock traded down 1.27%.
    • Treace Medical Concepts (NASDAQ:TMCI) shares hit a yearly low of $17.21. The stock was down 12.67% on the session.
    • Everbridge (NASDAQ:EVBG) shares made a new 52-week low of $21.32 on Wednesday. The stock was down 5.46% for the day.
    • Infinera (NASDAQ:INFN) shares fell to $3.64 on Wednesday, setting a new 52-week low with a shift of down 1.74%.
    • 23andMe Holding (NASDAQ:ME) stock hit $1.54 on Wednesday morning, setting a new 52-week low for a change of down 10.34%.
    • James River Gr Hldgs (NASDAQ:JRVR) stock drifted down 4.12% on Wednesday morning to hit a new 52-week low of $15.49.
    • AerSale (NASDAQ:ASLE) shares hit a yearly low of $10.93. The stock was down 23.42% on the session.
    • Seres Therapeutics (NASDAQ:MCRB) stock hit $3.99 on Wednesday morning, setting a new 52-week low for a change of down 2.8%.
    • American Well (NYSE:AMWL) shares hit a yearly low of $1.75. The stock was down 5.61% on the session.
    • Vertex Energy (NASDAQ:VTNR) shares fell to $4.27 on Wednesday, setting a new 52-week low with a shift of down 4.85%.
    • ITeos Therapeutics (NASDAQ:ITOS) stock set a new 52-week low of $11.78 on Wednesday, moving down 0.72%.
    • American Vanguard (NYSE:AVD) shares set a new 52-week low of $14.11. The stock traded down 16.18%.
    • uniQure (NASDAQ:QURE) shares were down 1.51% for the day, having made a 52-week low of $8.42.
    • Ioneer (NASDAQ:IONR) stock set a new 52-week low of $6.96 on Wednesday, moving down 5.71%.
    • American Lithium (NASDAQ:AMLI) stock drifted down 3.29% on Wednesday morning to hit a new 52-week low of $1.45.
    • Anika Therapeutics (NASDAQ:ANIK) shares set a new 52-week low of $19.98. The stock traded down 2.38%.
    • Emergent BioSolutions (NYSE:EBS) shares were down 17.01% for the day, having made a 52-week low of $5.75.
    • 2seventy bio (NASDAQ:TSVT) shares set a new yearly low of $5.71 this morning. The stock was down 0.78% on the session.
    • PetMed Express (NASDAQ:PETS) shares made a new 52-week low of $12.73 on Wednesday. The stock was down 1.07% for the day.
    • NL Industries (NYSE:NL) shares hit a yearly low of $5.36. The stock was up 1.12% on the session.
    • Sutro Biopharma (NASDAQ:STRO) shares were 0.0% (flat) for the day, having made a 52-week low of $4.08.
    • 2U (NASDAQ:TWOU) stock drifted down 27.69% on Wednesday morning to hit a new 52-week low of $2.96.
    • BRC (NYSE:BRCC) shares fell to $3.91 on Wednesday, setting a new 52-week low with a shift of down 2.72%.
    • Nutex Health (NASDAQ:NUTX) shares set a new yearly low of $0.33 this morning. The stock was up 0.21% on the session.
    • Vigil Neuroscience (NASDAQ:VIGL) shares reached a new 52-week low of $5.81 on Wednesday morning, moving down 1.15%.
    • I-MAB (NASDAQ:IMAB) stock achieved a new 52-week low on Wednesday morning, hitting $2.44 and moving down 0.4%.
    • Mesoblast (NASDAQ:MESO) shares set a new 52-week low of $1.19. The stock traded down 10.95%.
    • Braemar Hotels & Resorts (NYSE:BHR) shares hit a yearly low of $2.87. The stock was down 6.11% on the session.
    • Eaton Vance Municipal (NYSE:ETX) shares made a new 52-week low of $17.32 on Wednesday. The stock was up 0.01% for the day.
    • Sangamo Therapeutics (NASDAQ:SGMO) shares were down 6.58% for the day, having made a 52-week low of $1.05.
    • Full House Resorts (NASDAQ:FLL) shares were down 14.45% for the day, having made a 52-week low of $5.17.
    • Richardson Electronics (NASDAQ:RELL) shares set a new 52-week low of $12.57. The stock traded down 3.08%.
    • Regencell Bioscience (NASDAQ:RGC) shares made a new 52-week low of $13.00 on Wednesday. The stock was down 7.14% for the day.
    • Codexis (NASDAQ:CDXS) shares moved down 3.71% on Wednesday to hit a new 52-week low of $2.15, drifting down 3.71%.
    • ClearPoint Neuro (NASDAQ:CLPT) shares fell to $5.92 on Wednesday, setting a new 52-week low with a shift of down 2.97%.
    • Akoustis Technologies (NASDAQ:AKTS) shares made a new 52-week low of $2.10 on Wednesday. The stock was down 7.49% for the day.
    • Kezar Life Sciences (NASDAQ:KZR) shares set a new 52-week low of $2.03. The stock traded down 0.49%.
    • Altimmune (NASDAQ:ALT) shares moved down 1.16% on Wednesday to hit a new 52-week low of $2.89, drifting down 1.16%.
    • Amyris (NASDAQ:AMRS) shares set a new 52-week low of $0.38. The stock traded down 15.24%.
    • FibroGen (NASDAQ:FGEN) shares moved down 7.64% on Wednesday to hit a new 52-week low of $1.31, drifting down 7.64%.
    • KVH Industries (NASDAQ:KVHI) shares made a new 52-week low of $6.25 on Wednesday. The stock was down 27.24% for the day.
    • Complete Solaria (NASDAQ:CSLR) stock broke to a new 52-week low of $2.64 on Wednesday. Shares of the company traded down 5.9%.
    • Veritone (NASDAQ:VERI) shares reached a new 52-week low of $2.73 on Wednesday morning, moving down 30.82%.
    • Glatfelter (NYSE:GLT) shares reached a new 52-week low of $1.86 on Wednesday morning, moving down 0.33%.
    • Chimerix (NASDAQ:CMRX) shares set a new yearly low of $1.02 this morning. The stock was down 2.36% on the session.
    • VolitionRX (AMEX:VNRX) shares made a new 52-week low of $1.20 on Wednesday. The stock was down 0.83% for the day.
    • Astra Space (NASDAQ:ASTR) shares fell to $0.32 on Wednesday, setting a new 52-week low with a shift of down 4.12%.
    • Casa Systems (NASDAQ:CASA) stock hit $0.90 on Wednesday morning, setting a new 52-week low for a change of down 8.14%.
    • DZS (NASDAQ:DZSI) stock hit $2.61 on Wednesday morning, setting a new 52-week low for a change of down 11.76%.
    • TD Hldgs (NASDAQ:GLG) shares were up 1.52% for the day, having made a 52-week low of $0.45.
    • REE Automotive (NASDAQ:REE) stock broke to a new 52-week low of $0.26 on Wednesday. Shares of the company traded down 7.4%.
    • Singular Genomics Sys (NASDAQ:OMIC) stock hit $0.71 on Wednesday morning, setting a new 52-week low for a change of 0.0% (flat).
    • Marti Techs (AMEX:MRT) shares fell to $0.88 on Wednesday, setting a new 52-week low with a shift of down 12.74%.
    • Alpine 4 Holdings (NASDAQ:ALPP) shares reached a new 52-week low of $1.41 on Wednesday morning, moving down 5.94%.
    • Proterra (NASDAQ:PTRA) stock set a new 52-week low of $0.14 on Wednesday, moving down 4.19%.
    • Near Intelligence (NASDAQ:NIR) stock dropped to a yearly low on Wednesday of $0.65. Shares traded down 10.27%.
    • ESGL Holdings (NASDAQ:ESGL) stock drifted down 9.5% on Wednesday morning to hit a new 52-week low of $3.10.
    • Nautilus (NYSE:NLS) shares reached a new 52-week low of $0.95 on Wednesday morning, moving down 3.92%.
    • CalAmp (NASDAQ:CAMP) shares fell to $0.82 on Wednesday, setting a new 52-week low with a shift of down 1.19%.
    • Chicken Soup for the Soul (NASDAQ:CSSE) shares were down 2.88% for the day, having made a 52-week low of $0.99.
    • OncoCyte (NASDAQ:OCX) stock achieved a new 52-week low on Wednesday morning, hitting $3.48 and moving 0.0% (flat).
    • Aterian (NASDAQ:ATER) shares were down 10.26% for the day, having made a 52-week low of $0.33.
    • Warrantee (NASDAQ:WRNT) stock drifted down 6.67% on Wednesday morning to hit a new 52-week low of $1.23.
    • Medicenna Therapeutics (NASDAQ:MDNA) stock dropped to a yearly low on Wednesday of $0.35. Shares traded down 8.67%.
    • Nortech Systems (NASDAQ:NSYS) stock dropped to a yearly low on Wednesday of $8.76. Shares traded down 4.24%.
    • Lichen China (NASDAQ:LICN) shares fell to $0.81 on Wednesday, setting a new 52-week low with a shift of down 3.78%.
    • Interactive Strength (NASDAQ:TRNR) stock hit $1.51 on Wednesday morning, setting a new 52-week low for a change of down 5.52%.
    • NRX Pharmaceuticals (NASDAQ:NRXP) shares fell to $0.30 on Wednesday, setting a new 52-week low with a shift of down 0.7%.
    • ProMIS Neurosciences (NASDAQ:PMN) shares were down 6.34% for the day, having made a 52-week low of $2.30.
    • Salem Media Group (NASDAQ:SALM) stock achieved a new 52-week low on Wednesday morning, hitting $0.66 and moving down 18.49%.
    • Phoenix New Media (NYSE:FENG) shares were up 2.67% for the day, having made a 52-week low of $1.40.
    • Castellum (AMEX:CTM) stock hit $0.34 on Wednesday morning, setting a new 52-week low for a change of up 5.63%.
    • Vaccinex (NASDAQ:VCNX) stock drifted down 1.19% on Wednesday morning to hit a new 52-week low of $0.25.
    • Erayak Power Solution Gr (NASDAQ:RAYA) shares set a new 52-week low of $1.18. The stock traded down 15.53%.
    • Multi Ways Holdings (AMEX:MWG) stock broke to a new 52-week low of $0.45 on Wednesday. Shares of the company traded down 6.79%.
    • Remark Hldgs (NASDAQ:MARK) shares made a new 52-week low of $0.86 on Wednesday. The stock was down 4.06% for the day.
    • Visionary Education Tech (NASDAQ:VEDU) shares fell to $0.30 on Wednesday, setting a new 52-week low with a shift of down 0.03%.
    • Avalon Globocare (NASDAQ:ALBT) stock dropped to a yearly low on Wednesday of $1.15. Shares traded up 1.67%.
    • SeaChange International (NASDAQ:SEAC) shares set a new yearly low of $4.53 this morning. The stock was down 1.28% on the session.
    • Carver Bancorp (NASDAQ:CARV) shares fell to $2.43 on Wednesday, setting a new 52-week low with a shift of down 2.8%.
    • Venus Concept (NASDAQ:VERO) shares hit a yearly low of $1.81. The stock was up 5.39% on the session.
    • Marpai (NASDAQ:MRAI) stock hit a yearly low of $1.33. The stock was up 0.7% for the day.
    • Ontrak (NASDAQ:OTRK) shares hit a yearly low of $1.99. The stock was down 5.0% on the session.
    • Air Industries (AMEX:AIRI) stock hit a yearly low of $3.01. The stock was down 1.3% for the day.
    • Treasure Global (NASDAQ:TGL) shares fell to $0.54 on Wednesday, setting a new 52-week low with a shift of down 9.75%.
    • GRI Bio (NASDAQ:GRI) stock drifted up 0.31% on Wednesday morning to hit a new 52-week low of $3.15.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares reached a new 52-week low of $1.21 on Wednesday morning, moving down 9.74%.
    • ABVC BioPharma (NASDAQ:ABVC) stock hit a yearly low of $2.35. The stock was up 2.08% for the day.
    • 60 Degrees (NASDAQ:SXTP) shares set a new 52-week low of $1.48. The stock traded 0.0% (flat).
    • Golden Minerals (AMEX:AUMN) shares reached a new 52-week low of $1.03 on Wednesday morning, moving down 5.4%.
    • Athersys (NASDAQ:ATHX) stock set a new 52-week low of $0.39 on Wednesday, moving down 6.06%.
    • Reborn Coffee (NASDAQ:REBN) shares moved down 4.02% on Wednesday to hit a new 52-week low of $0.63, drifting down 4.02%.
    • Yield10 Bioscience (NASDAQ:YTEN) shares moved down 18.37% on Wednesday to hit a new 52-week low of $1.32, drifting down 18.37%.
    • Fangdd Network Group (NASDAQ:DUO) shares moved down 4.15% on Wednesday to hit a new 52-week low of $1.93, drifting down 4.15%.
    • SeaStar Medical Holding (NASDAQ:ICU) shares moved down 5.21% on Wednesday to hit a new 52-week low of $0.40, drifting down 5.21%.
    • Micromobility com (NASDAQ:MCOM) stock broke to a new 52-week low of $0.06 on Wednesday. Shares of the company traded down 5.13%.
    • Siyata Mobile (NASDAQ:SYTA) shares fell to $3.12 on Wednesday, setting a new 52-week low with a shift of up 7658.62%.
    • Adial Pharmaceuticals (NASDAQ:ADIL) stock hit a yearly low of $4.92. The stock was down 10.02% for the day.
    • Applied UV (NASDAQ:AUVI) stock broke to a new 52-week low of $0.65 on Wednesday. Shares of the company traded down 8.93%.
    • Benitec Biopharma (NASDAQ:BNTC) stock dropped to a yearly low on Wednesday of $1.86. Shares traded up 84.17%.
    • Jiuzi Hldgs (NASDAQ:JZXN) stock hit $1.27 on Wednesday morning, setting a new 52-week low for a change of up 2.96%.
    • Freight Technologies (NASDAQ:FRGT) shares were down 2.93% for the day, having made a 52-week low of $0.55.
    • Lixte Biotech Hldgs (NASDAQ:LIXT) shares set a new 52-week low of $2.69. The stock traded down 6.76%.
    • Swvl Hldgs (NASDAQ:SWVL) shares fell to $0.89 on Wednesday, setting a new 52-week low with a shift of down 9.8%.
    • Nexalin Technology (NASDAQ:NXL) shares set a new yearly low of $0.66 this morning. The stock was down 1.45% on the session.
    • Aptevo Therapeutics (NASDAQ:APVO) stock broke to a new 52-week low of $0.47 on Wednesday. Shares of the company traded up 0.81%.
    • Palisade Bio (NASDAQ:PALI) stock hit $0.60 on Wednesday morning, setting a new 52-week low for a change of down 64.46%.
    • Synaptogenix (NASDAQ:SNPX) stock dropped to a yearly low on Wednesday of $0.57. Shares traded down 1.96%.
    • SMX (Security Matters) (NASDAQ:SMX) shares reached a new 52-week low of $0.10 on Wednesday morning, moving down 2.94%.
    • Phio Pharma (NASDAQ:PHIO) shares made a new 52-week low of $2.34 on Wednesday. The stock was down 3.14% for the day.
    • Shineco (NASDAQ:SISI) shares set a new 52-week low of $0.20. The stock traded down 4.31%.
    • Kiora Pharmaceuticals (NASDAQ:KPRX) stock hit $0.55 on Wednesday morning, setting a new 52-week low for a change of down 0.11%.
    • Actelis Networks (NASDAQ:ASNS) stock hit a yearly low of $1.78. The stock was down 11.82% for the day.
    • Digital Brands Group (NASDAQ:DBGI) stock drifted down 0.52% on Wednesday morning to hit a new 52-week low of $0.39.
    • Avalo Therapeutics (NASDAQ:AVTX) shares set a new yearly low of $0.14 this morning. The stock was down 9.64% on the session.
    • Agile Therapeutics (NASDAQ:AGRX) stock drifted down 6.95% on Wednesday morning to hit a new 52-week low of $2.23.
    • Salarius Pharmaceuticals (NASDAQ:SLRX) stock dropped to a yearly low on Wednesday of $0.72. Shares traded down 12.27%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $TSVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TSVT
    $TWOU
    $ULCC
    $VCNX

    CompanyDatePrice TargetRatingAnalyst
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    Estee Lauder Companies Inc.
    $EL
    2/6/2026$120.00Neutral → Buy
    Citigroup
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$31.00Outperform
    Leerink Partners
    Aktis Oncology Inc.
    $AKTS
    2/3/2026Buy
    TD Cowen
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    uniQure N.V.
    $QURE
    1/28/2026$31.00Equal Weight
    Barclays
    More analyst ratings

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    April 26, 2023 - FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection

    For Immediate Release: April 26, 2023 Today, the U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally. Vowst is approved for the prevention of recurrence of Clostridioides difficile (C. difficile) infection (CDI) in individuals 18 years of age and older, following antibacterial treatment for recurrent CDI.  “Today’s approval provides patients and healthcare p

    4/26/23 6:04:21 PM ET
    $MCRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Xencor Inc.

    SCHEDULE 13G - Xencor Inc (0001326732) (Subject)

    2/9/26 8:12:57 AM ET
    $XNCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by uniQure N.V.

    SCHEDULE 13G - uniQure N.V. (0001590560) (Subject)

    2/9/26 8:10:32 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 15-12G filed by Venus Concept Inc.

    15-12G - Venus Concept Inc. (0001409269) (Filer)

    2/9/26 7:15:41 AM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Abg Management Ltd. bought $8,499,988 worth of shares (700,741 units at $12.13) (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    2/5/26 7:00:01 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Glenbrook Capital Management bought $94,524 worth of shares (48,138 units at $1.96) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/3/26 5:27:37 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Brandon Craig R acquired 325 shares, increasing direct ownership by 5% to 6,647 units (SEC Form 5)

    5 - Eaton Vance Municipal Income 2028 Term Trust (0001563696) (Issuer)

    2/6/26 12:01:10 PM ET
    $ETX
    Investment Managers
    Finance

    CFO, CAO, Corporate Secretary Ben Robert J sold $59,503 worth of shares (5,000 units at $11.90), decreasing direct ownership by 8% to 57,034 units (SEC Form 4)

    4 - RICHARDSON ELECTRONICS, LTD. (0000355948) (Issuer)

    2/6/26 10:11:09 AM ET
    $RELL
    Electronic Components
    Technology

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium

    Virtual fireside chat scheduled for Thursday, February 12, 2026, from 1:30 PM to 1:55 PM ET Access the webcast here Carlsbad, CA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President and Chief Medical Officer, will participate in a virtual fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium on Thursday, February 12, 2026, from 1:30 PM to 1:55 PM ET. Th

    2/9/26 9:00:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

    Strong survival data extending to 90 days Real-world experience shows results consistent with clinical trial data Favorable safety profile – no device-related adverse events DENVER, Feb. 09, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company, announced today the publication of early post-approval clinical experience from the use of the QUELIMMUNE (Selective Cytopheretic Device for Pediatrics, or SCD-PED) therapy in the prestigious, peer-reviewed journal Pediatric Nephrology. The publication, co-authored by leading experts including Stuart Goldstein, Kelli Krallman, Meredith Harris, Rajit Basu, David Askenazi, Shina Menon, Ma

    2/9/26 8:20:00 AM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Swvl Secures a New Up to $1.5 Million Multi-Year Contract in Saudi Arabia, Expanding Its Healthcare Mobility Footprint Across the GCC

    DUBAI, United Arab Emirates, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Swvl Holdings Corp ("Swvl" or the "Company") (NASDAQ:SWVL), a leading provider of technology-enabled mass mobility solutions, today announced the signing of a new three-year contract valued at up to $1.5 million in the Kingdom of Saudi Arabia ("KSA"), marking a significant expansion of its healthcare mobility operations across the Gulf Cooperation Council ("GCC"). The agreement will support patient, medical staff, and equipment transportation across healthcare facilities, leveraging Swvl's technology platform to enable dynamic route planning, real-time dispatching, and operational optimization. The deployment is designed to su

    2/9/26 7:00:00 AM ET
    $SWVL
    Real Estate

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Impinj downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Impinj from Outperform to In-line and set a new price target of $112.00

    2/6/26 8:09:28 AM ET
    $PI
    Industrial Machinery/Components
    Technology

    Estee Lauder upgraded by Citigroup with a new price target

    Citigroup upgraded Estee Lauder from Neutral to Buy and set a new price target of $120.00

    2/6/26 8:05:27 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Analyst initiated coverage on Aktis Oncology with a new price target

    Analyst initiated coverage of Aktis Oncology with a rating of Overweight and set a new price target of $30.00

    2/3/26 6:54:43 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Financials

    Live finance-specific insights

    View All

    Impinj Reports Fourth Quarter and Full Year 2025 Financial Results

    Impinj, Inc. (NASDAQ:PI), a leading RAIN RFID provider and Internet of Things pioneer, today released its financial results for the fourth quarter and year ended December 31, 2025. "2025 was a transition year for Impinj. We grew year-over-year endpoint IC volumes, made M800 our volume runner, launched Gen2X and exited the year with record adjusted EBITDA and cash," said Chris Diorio, Impinj co-founder and CEO. "As we continue driving our bold vision, I remain confident in our market position and energized by the opportunities ahead." Fourth Quarter 2025 Financial Summary Revenue of $92.8 million GAAP gross margin of 51.8%; non-GAAP gross margin of 54.5% GAAP net loss of $1.1 mi

    2/5/26 4:15:00 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Amwell® to report fourth quarter and full year 2025 operating results

    BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report fourth quarter and full year 2025 operating results after stock market trading hours on Thursday, Feb. 12. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at

    2/5/26 4:05:00 PM ET
    $AMWL
    Real Estate

    Full House Resorts Announces Fourth Quarter Earnings Release Date

    LAS VEGAS, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Full House Resorts (NASDAQ:FLL) announced today that it will report its fourth quarter 2026 financial results on Thursday, March 5, 2026, followed by a conference call at 4:30 p.m. ET (1:30 p.m. PT). Investors can access the live audio webcast from the Company's website at www.fullhouseresorts.com under the investor relations section. The conference call can also be accessed by dialing (201) 689-8470. A replay of the conference call will be available shortly after the conclusion of the call through March 19, 2026. To access the replay, please visit www.fullhouseresorts.com. Investors can also access the replay by dialing (412) 317-6671 and usin

    2/5/26 9:00:00 AM ET
    $FLL
    Hotels/Resorts
    Consumer Discretionary

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Leadership Updates

    Live Leadership Updates

    View All

    FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company

    Company reports 2025 fourth quarter and full year results, provides 2026 outlook  The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredientsThe FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure its growth and core portfolios are best positioned for long-term success PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 prioritie

    2/4/26 5:00:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors

    NEWTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to its Board of Directors. Dr. Blanchard is an accomplished biotech and medtech CEO and board member with more than 30 years of experience building, scaling, and transforming public and private life sciences companies. Dr. Blanchard most recently served as President, CEO, and Director of Anika Therapeutics (NASDAQ:ANIK), where she led the successful implementat

    2/4/26 8:54:00 AM ET
    $ANIK
    Medical/Dental Instruments
    Health Care

    Richardson Electronics' Canvys Division Appoints Rainer Bornwasser as VP of Global Sales

    LAFOX, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ:RELL), today announced that Rainer Bornwasser has been appointed Vice President of Global Sales for Canvys – Visual Technology Solutions, a division of Richardson Electronics, effective February 1, 2026. The appointment underscores Richardson Electronics' commitment to accelerating global growth, expanding strategic OEM partnerships, and strengthening its position in high-value medical and industrial display markets through its Canvys division. For conference questions and registration information, please contact your Benchmark representative. Mr. Bornwasser brings more than 30 years of international sales

    2/3/26 11:00:00 AM ET
    $RELL
    Electronic Components
    Technology

    $TSVT
    $TWOU
    $ULCC
    $VCNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care